Times Live Blog: Promising results in blocking HIV during first days of infection: M2010
June 2010
Up one levelTimes Live Blog: Promising results in blocking HIV during first days of infection: M2010
by Claire Keeton (24 May 2010): Two pilot studies to test an innovative way to block SIV (the monkey version of HIV) infection early on are showing encouraging results, Dr Ashley Hasse told a plenary session this morning at the M2010 Microbicides conference in Pittsburgh.
Times Live Blog: New drugs in the pipeline for anti-HIV microbicides: results presented at M2010
by Claire Keeton (24 May 2010): SCIENTISTS today presented “promising data” on what drugs could prove effective in the next generation of microbicides to stop the sexual transmission of HIV.
Times Live Blog: Where was the polio vaccine discovered?
by Claire Keeton (23 May 2010): Pittsburgh, the host city of the M2010 Microbicides conference this week, is also the city where Jonas Salk developed the polio vaccine.
Times Live Blog: Women like using anti-HIV microbicide gels during sex
by Claire Keeton (23 May 2010): Microbicide gels are acceptable to most women during sex, the results of three studies presented today at the M2010 Microbicides conference showed.
Times Live: Microbicides progressing well in fight against HIV
by Claire Keeton (24 May 2010): The development of new microbicides to protect against HIV infection is progressing steadily with promising options in the pipeline, researchers reported today at the M2010 Microbicides conference in Pittsburgh, in the US.
Times Live: Partner pregnant? HIV risk doubles
by Claire Keeton (24 May 2010): The risk of men being infected by HIV doubles when their partners are pregnant, according to new findings presented today at the M2010 Microbicides: Building Bridges in HIV Prevention conference.
The Standard: HIV researchers congregate in the US
bt Tsitsi Jonas (23 May 2010): ZIMBABWEAN researchers will this week join experts from the rest of the world searching for more effective HIV prevention methods at the International Microbicides Conference in Pittsburgh, United States.
Citizen-News: Not just a handmaiden: Critical role of social science in HIV Prevention Research
by Bobby Ramakant (25 May 2010): It is well understood that both the efficacy and effectiveness of HIV Prevention research trial products (such as microbicides) depends upon their actual use by the clinical trial participants. “Use is a function of human behavior and action that is affected by an individual, interpersonal, social, and cultural factors that operate interactively in complex, dynamic and varied ways across settings” said Dr Judith D Auerbach, Vice President for Science and Public Policy at the San Francisco AIDS Foundation, USA.
Citizen-News: State of the ART of microbicides
by Bobby Ramakant (23 May 2010): The microbicides field has undoubtedly moved and shifted a lot in the past decade. Now, with first generation microbicides candidate products up and gone, antiretroviral treatment (ART)-drug based microbicides in spotlight, and only three major microbicides efficacy studies remaining, the need to lobby for increased funding of microbicides research and development, was never so compelling.
New vaginal ring borrows from birth control to fight AIDS
WASHINGTON— 9 June 2010: A non-profit that develops drugs against HIV/AIDS said Tuesday it is launching the first study in Africa of a groundbreaking device to fight AIDS: a vaginal ring with a difference.
ARV Vaginal Ring Next Prevention Hope
By Lungi Langa (Health-e News) 8 June 2010: Researchers have started testing the safety a vaginal ring containing an antiretroviral drug in South Africa in the hope that it has the potential to prevent HIV infection in women.
To stop Aids, we must empower women
Opinion piece by Elizabeth Mataka and Zeda Rosenberg (The Citizen: Tanzania news) 7 June 2010: African women are no strangers to overcoming adversity. Every day across Tanzania, women perform small miracles, working long hours or traveling great distances to provide for their families. Increasingly, they are starting small businesses and running for office—while at the same time tending homes and raising children.
Microbicides set to empower women
By Bertha Shoko, recently in Pittsburgh, US (The Zimbabwe Standard) 5 June 2010: Researchers exploring possibilities of a prevention method that will help protect women from HIV infection are hopeful that the first clinical trials assessing the effectiveness of an Antiretroviral (ARV)-based microbicide gel running in a number of countries including Zimbabwe will yield positive results.